HRT litigation rolls on 
By Nora Lockwood Tooher -
Published: August 31, 2010
Tags: hormone replacement therapy litigation, Pfizer, Premarin, Prempro, Provera, Upjohn, Wyeth
With Pfizer and plaintiffs’ lawyers squabbling over who has won the most hormone replacement therapy trials, only one thing about the litigation is clear: it’s turning into one of the longest-running mass torts in U.S. history.
Pfizer settles Prempro case before damages retrial
Published: August 30, 2010
Tags: Arkansas, breast cancer, Pfizer, Prempro
Pfizer Inc. has agreed to settle an Arkansas woman’s claims that the company’s Prempro menopause drug caused her breast cancer before the drugmaker endured another trial over punitive damages in the case, according to a court filing.
Pfizer settles Neurontin wrongful death suit
Published: May 18, 2010
Tags: Neurontin, off-label uses, Pfizer, wrongful death
A settlement has been reached in the third Neurontin wrongful death case, which was scheduled to begin trial Tuesday in U.S. District Court in Nashville, Tenn.
New trial in hormone replacement therapy case
Published: May 11, 2010
Tags: drug litigation, hormone replacement therapy, Pfizer, Provera
Pfizer is entitled to a new trial in a hormone replacement therapy drug suit, a trial court judge in Pennsylvania has ruled.
Scientist wins whistleblower suit against Pfizer
Published: April 19, 2010
Tags: Pfizer, virus
A U.S. District Court jury has awarded $1.37 million to a former Pfizer scientist who says she was exposed to a virus designed at the company’s labs in Groton, Conn.
Jurors in Neurontin trial hear opening arguments
By Nora Lockwood Tooher -
Published: March 31, 2010
Tags: Neurontin, off-label uses, Pfizer
BOSTON - Plaintiffs’ lawyer Ronald Rosenkranz urged jurors Wednesday to hold Pfizer Inc. liable for the death of Hartley Shearer, who committed suicide in 2002 after taking Neurontin for 16 months.
Jury selection begins in Neurontin suicide trial
By Nora Lockwood Tooher -
Published: March 29, 2010
Tags: Neurontin, off-label uses, Pfizer
BOSTON - Jury selection began Monday in the second wrongful death trial alleging Pfizer’s off-label promotion of its anti-epilepsy drug Neurontin caused a patient to commit suicide.
Pfizer ordered to pay $142M for Neurontin marketing fraud
Published: March 26, 2010
Tags: Kaiser, Neurontin, off-label uses, Pfizer
BOSTON - A federal jury Thursday found that Pfizer violated anti-racketeering laws in promoting its epilepsy drug Neurontin for unapproved uses and must pay at least $142 million in damages.
Prempro litigation slugfest continues
By Nora Lockwood Tooher -
Published: February 26, 2010
Tags: hormone replacement therapy, HRT litigation, Pfizer, Prempro, Wyeth
The Prempro litigation in Philadelphia is turning into a Rocky-style slugfest, with both sides vowing to continue fighting it out in court.
NY judge dismisses 23 HRT lawsuits
Published: December 22, 2009
Tags: hormone replacement therapy, Pfizer, Prempro, Wyeth
A New York trial court judge has dismissed lawsuits brought by 23 women who claim hormone replacement therapy drugs manufactured by Wyeth caused them to develop breast cancer.
FREE White Papers
Most Viewed Stories
Stay Connected with Lawyers USA
Lawyers USA keeps you connected with all the latest news affecting you and your practice with Daily, Practice and Breaking News alerts.
To Sign-up or Manage your Alerts, click here.
